Myomo (MYO) FCF Margin Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 261.00 |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -885.00 |
| Jun 30, 2025 | -8,476.00 |
| Mar 31, 2025 | 6,081.00 |
| Dec 31, 2024 | 7,095.00 |
| Sep 30, 2024 | 1,511.00 |
| Jun 30, 2024 | -2,202.00 |
| Mar 31, 2024 | -3,402.00 |
| Dec 31, 2023 | 1,086.00 |
| Sep 30, 2023 | 3,585.00 |
| Jun 30, 2023 | 6,840.00 |
| Mar 31, 2023 | 732.00 |
| Dec 31, 2022 | -1,511.00 |
| Sep 30, 2022 | -1,880.00 |
| Jun 30, 2022 | 4,222.00 |
| Mar 31, 2022 | 3,099.00 |
| Dec 31, 2021 | -1,565.00 |
| Sep 30, 2021 | 4,272.00 |
| Jun 30, 2021 | 31,003.00 |
| Mar 31, 2021 | 15,098.00 |
| Dec 31, 2020 | 14,448.00 |
| Sep 30, 2020 | 28,351.00 |
| Jun 30, 2020 | -16,250.00 |
| Mar 31, 2020 | 13,320.00 |
| Dec 31, 2019 | 10,879.00 |
| Sep 30, 2019 | 3,552.00 |
| Jun 30, 2019 | 11,024.00 |
| Mar 31, 2019 | 36,756.00 |
| Dec 31, 2018 | 177,967.00 |
| Sep 30, 2018 | -3,156.00 |
| Jun 30, 2018 | 14,370.00 |
| Mar 31, 2018 | 555,868.00 |
| Dec 31, 2017 | -186,152.00 |
| Sep 30, 2017 | 33,149.00 |